These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for candidemia-related mortality at a medical center in central Taiwan. Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW. J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249 [Abstract] [Full Text] [Related]
3. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
4. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT, Velasco D, Canle D, Moure R, Villanueva R. Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [Abstract] [Full Text] [Related]
5. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society. Yamamura DL, Rotstein C, Nicolle LE, Ioannou S. CMAJ; 1999 Feb 23; 160(4):493-9. PubMed ID: 10081465 [Abstract] [Full Text] [Related]
6. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH, Morrissey CO, Chen SC, Australian Candidemia Study, Australasian Society for Infectious Diseases. J Antimicrob Chemother; 2010 May 23; 65(5):1042-51. PubMed ID: 20202987 [Abstract] [Full Text] [Related]
10. [Epidemiology of candidemia: a one-year prospective observational study in the west of France]. Talarmin JP, Boutoille D, Tattevin P, Dargère S, Weinbreck P, Ansart S, Chennebault JM, Hutin P, Léautez-Nainville S, Gay-Andrieu F, Raffi F, le GERICCO. Med Mal Infect; 2009 Dec 23; 39(12):877-85. PubMed ID: 19346088 [Abstract] [Full Text] [Related]
14. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group. Crit Care Med; 2009 May 01; 37(5):1612-8. PubMed ID: 19325476 [Abstract] [Full Text] [Related]
15. Epidemiology of candidemia at a Children's hospital, 2002 to 2006. Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, Saiman L. Pediatr Infect Dis J; 2009 Sep 01; 28(9):806-9. PubMed ID: 19636286 [Abstract] [Full Text] [Related]
16. Epidemiology of candidemia in a Turkish tertiary care hospital. Bakir M, Cerikcioglu N, Barton R, Yagci A. APMIS; 2006 Sep 01; 114(9):601-10. PubMed ID: 16948812 [Abstract] [Full Text] [Related]
17. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981 [Abstract] [Full Text] [Related]
18. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Diagn Microbiol Infect Dis; 2005 Aug 15; 52(4):295-8. PubMed ID: 15922535 [Abstract] [Full Text] [Related]
20. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B. J Antimicrob Chemother; 2008 Dec 15; 62(6):1379-85. PubMed ID: 18782778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]